Vaccine Contract Manufacturing Market Size, Share & Trends Analysis Report By Vaccine Type (Attenuated, Inactivated, Subunit-based, Toxoid-based, DNA-based), By Type of Expression System, By Workflow, By Application, By Region, And By Segment Forecasts, 2025-2034

Report Id: 2303 Pages: 179 Last Updated: 04 March 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Vaccine Contract Manufacturing Market-

Vaccine Contract Manufacturing Market By Vaccine Type

  • Attenuated
  • Inactivated
  • Subunit-based
  • Toxoid-based
  • DNA-based 

Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market By Type of Expression System

  • Avian Expression Systems
  • Bacterial Expression Systems
  • Embryonated Chicken Eggs and Primary Chicken Embryonic Fibroblasts (CEFs)
  • Insect Expression Systems
  • Mammalian Expression Systems
  • Plant Expression Systems
  • Yeast Expression Systems

Vaccine Contract Manufacturing Market By Workflow

  • Downstream
  • Upstream

Vaccine Contract Manufacturing Market By Application

  • Human Use
  • Veterinary

Vaccine Contract Manufacturing Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Vaccine Contract Manufacturing Market Snapshot

Chapter 4. Global Vaccine Contract Manufacturing Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Technology Advancement in Vaccine Contract Manufacturing Market

4.8. Key Trends in the Market

Chapter 5. Market Segmentation 1: Vaccine Type Estimates & Trend Analysis

5.1. Vaccine Type & Market Share, 2024 & 2034

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Vaccine Type:

5.2.1. Avian Expression Systems

5.2.2. Bacterial Expression Systems

5.2.3. Embryonated Chicken Eggs and Primary Chicken Embryonic Fibroblasts (CEFs)

5.2.4. Insect Expression Systems

5.2.5. Mammalian Expression Systems

5.2.6. Plant Expression Systems

5.2.7. Yeast Expression Systems

Chapter 6. Market Segmentation 2: Type of Expression System Estimates & Trend Analysis

6.1. Type of Expression System & Market Share, 2024 & 2034

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Expression System:

6.2.1. Attenuated

6.2.2. Inactivated

6.2.3. Subunit-based

6.2.4. Toxoid-based

6.2.5. DNA-based

Chapter 7. Market Segmentation 3: Workflow Estimates & Trend Analysis

7.1. Workflow & Market Share, 2024 & 2034

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Workflow:

7.2.1. Downstream

7.2.2. Upstream

Chapter 8. Market Segmentation 4: Application Estimates & Trend Analysis

8.1. Application & Market Share, 2024 & 2034

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

8.2.1. Human Use

8.2.2. Veterinary

Chapter 9. Vaccine Contract Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034

9.1.2. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034

9.1.3. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034

9.1.4. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034

9.1.5. North America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.1.5.1. U.S.

9.1.5.2. Canada

9.2. Europe

9.2.1. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034

9.2.2. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034

9.2.3. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034

9.2.4. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034

9.2.5. Europe Vaccine Contract Manufacturing Market revenue (US$ Million) by country, 2021-2034

9.2.5.1. Germany

9.2.5.2. France

9.2.5.3. Italy

9.2.5.4. Spain

9.2.5.5. UK

9.2.5.6. Rest of Europe

9.3. Asia Pacific

9.3.1. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034

9.3.2. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034

9.3.3. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034

9.3.4. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034

9.3.5. Asia Pacific Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.3.5.1. China

9.3.5.2. India

9.3.5.3. Japan

9.3.5.4. Australia

9.3.5.5. Rest of Asia Pacific

9.4. Latin America

9.4.1. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034

9.4.2. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034

9.4.3. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034

9.4.4. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034

9.4.5. Latin America Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.4.5.1. Brazil

9.4.5.2. Rest of Latin America

9.5. MEA

9.5.1. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Vaccine Type, 2021-2034

9.5.2. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Type of Expression System, 2021-2034

9.5.3. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Workflow, 2021-2034

9.5.4. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034

9.5.5. MEA Vaccine Contract Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

9.5.5.1. GCC Countries

9.5.5.2. South Africa

9.5.5.3. Rest of MEA

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Lonza

10.2.2. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

10.2.3. Ajinomoto Althea, Inc.

10.2.4. Merck KgaA

10.2.5. Cytovance Biologics

10.2.6. Catalent, Inc.

10.2.7. IDT Biologika GmbH

10.2.8. Albany Molecular Research, Inc.

10.2.9. PRA Health Sciences

10.2.10. ICON plc.

10.2.11. Pharmaceutical Product Development, LLC

10.2.12. Cobra Bio

10.2.13. Paragon Bioservices, Inc.

10.2.14. Charles River Laboratories

10.2.15. Meridian Life Science (MLS)

10.2.16. Eurogentec

10.2.17. GreenPak Biotech

10.2.18. Hong Kong Institute of Biotechnology

10.2.19. WuXi Biologics

10.2.20. Bharat Biotech

10.2.21. Biological E

10.2.22. Other Prominent Player

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7543
Security Code field cannot be blank!

Frequently Asked Questions

Vaccine Contract Manufacturing Market Size is valued at USD 2.3 Bn in 2024 and is predicted to reach USD 3.9 Bn by the year 2034

Vaccine Contract Manufacturing Market is expected to grow at a 6.0% CAGR during the forecast period for 2025-2034.

Paragon Bioservices, Inc., Charles River Laboratories, Meridian Life Science (MLS), Eurogentec, GreenPak Biotech, Hong Kong Institute of Biotechnology

vaccine contract manufacturing is segmented on the basis of Vaccine Type, Type of Expression System, Workflow, and Application.

North American region is leading the Vaccine Contract Manufacturing Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying